首页> 外文OA文献 >Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus

【2h】

Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus

机译：羟基氯喹是患有全身性狼疮红斑狼疮的慢性肾病风险的中性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chia-Ying Wu; Magdalene Tan; Jing-Yang Huang; Jeng-Yuan Chiou; James Cheng-Chung Wei;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI) [J] . Naoto Yokogawa, Yukihiko Kato, Shoji Sugii, Modern Rheumatology . 2012,第2期

机译：日本人系统性红斑狼疮对羟氯喹的反应，使用皮肤性红斑狼疮的疾病面积和严重程度指数（CLASI）
2. Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI) [J] . YokogawaN., KatoY., SugiiS., Modern rheumatology . 2012,第2期

机译：日本人系统性红斑狼疮对羟氯喹的反应，使用皮肤性红斑狼疮的疾病面积和严重程度指数（CLASI）
3. Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US US Medicaid Systemic Lupus Erythematosus Population, 2000–2010 [J] . Lin Tzu‐Chieh, Marmor Michael F., Barbhaiya Medha, Arthritis care & research . 2018,第11期

机译：基线视网膜检查系统狼疮患者红斑狼疮新兴发起羟基氯喹治疗美国的Medicato补充Systemic狼疮红斑狼疮，2000-2010
4. Label-free Proteomic Profiling to Detect Novel Proteins for Systemic Lupus Erythematosus (SLE) Kidney Damage during Disease Flaring [C] . Lining Qi, Michael Bennett, Prasad Devarajan, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：无标记的蛋白质组学分析，用于检测全身狼疮性红斑狼疮（SLE）肾脏损伤的新型蛋白质
5. Studying the pathogenesis of kidney and central nervous system disease in systemic lupus erythematosus. [D] . Gao, Hua-Xin. 2009

机译：研究系统性红斑狼疮的肾脏和中枢神经系统疾病的发病机理。
6. Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus [O] . Deng-Ho Yang, Pui-Ying Leong, Sung-Kien Sia, 2019

机译：系统性红斑狼疮患者的长期羟氯喹治疗和冠状动脉疾病风险
7. Response to: ‘Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus’ by Wuet al [O] . Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas 2020

机译：回应：“羟基氯喹是沃特·卢特患者患者患者患者慢性肾病风险的中性

Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus

著录项

引文网络

相似文献

相关主题

期刊订阅